A quantitative proteomics-based signature of platinum sensitivity in ovarian cancer cell lines.
暂无分享,去创建一个
Robert Lucito | Kazimierz O Wrzeszczynski | Darryl J Pappin | R. Lucito | K. Wrzeszczynski | D. Pappin | N. Tonks | Cexiong Fu | Cexiong Fu | G. Su | Nicholas K Tonks | G. Fan | Gang Su | Gaofeng Fan
[1] Nevenka Dimitrova,et al. Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation , 2009, Nucleic acids research.
[2] Biaoyang Lin,et al. Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels*S , 2006, Molecular & Cellular Proteomics.
[3] Ruedi Aebersold,et al. Protein expression changes in ovarian cancer during the transition from benign to malignant. , 2012, Journal of proteome research.
[4] A. Mes-Masson,et al. Comparative proteome analysis of human epithelial ovarian cancer , 2007, Proteome Science.
[5] Y. Yoshioka,et al. Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells. , 2012, Biochemical and biophysical research communications.
[6] Katrin Marcus,et al. Quantitative Methods in Proteomics , 2012, Methods in Molecular Biology.
[7] A. Skubitz,et al. Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum , 2010, Proteome Science.
[8] J. Peterson,et al. Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells. , 2009, Cellular signalling.
[9] R. Xiang,et al. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach , 2012, Journal of cellular biochemistry.
[10] Marie Locard-Paulet,et al. Analysing signalling networks by mass spectrometry , 2012, Amino Acids.
[11] M. Dimopoulos,et al. Replication Protein A in Nonearly Ovarian Adenocarcinomas: Correlation With MCM-2, MCM-5, Ki-67 Index and Prognostic Significance , 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[12] D. Ong,et al. Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. , 2001, Cancer research.
[13] Ida Landini,et al. Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c). , 2014, Journal of proteomics.
[14] Michael Q. Zhang,et al. Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer , 2011, PloS one.
[15] Akihiko Yoshida,et al. Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. , 2011, Journal of proteomics.
[16] J. Stenvang,et al. Silencing of microRNA families by seed-targeting tiny LNAs , 2011, Nature Genetics.
[17] M. Tsao,et al. Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] J. Inazawa,et al. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors. , 2014, Human pathology.
[19] Albert Sickmann,et al. Robust Workflow for iTRAQ-Based Peptide and Protein Quantification , 2012, Quantitative Methods in Proteomics.
[20] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[21] L. Galluzzi,et al. Molecular mechanisms of cisplatin resistance , 2012, Oncogene.
[22] T. Chou,et al. Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2 , 2012, Clinical Cancer Research.
[23] A. Modesti,et al. Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds. , 2012, Metallomics.
[24] Vinay Varadan,et al. DNA methylation patterns in luminal breast cancers differ from non‐luminal subtypes and can identify relapse risk independent of other clinical variables , 2011, Molecular oncology.
[25] S. Cannistra,et al. Gene-expression profiling in epithelial ovarian cancer , 2008, Nature Clinical Practice Oncology.
[26] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[27] F. Pontén,et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer , 2010, Journal of Translational Medicine.
[28] H. Hornshøj,et al. Transcriptomic and proteomic profiling of two porcine tissues using high-throughput technologies , 2009, BMC Genomics.
[29] Songying Zhang,et al. Calcium-binding protein S100P and cancer: mechanisms and clinical relevance , 2011, Journal of Cancer Research and Clinical Oncology.
[30] C. Smythe,et al. Purification and identification of secernin, a novel cytosolic protein that regulates exocytosis in mast cells. , 2002, Molecular biology of the cell.
[31] D. Fishman,et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. , 2002, Cancer research.
[32] S. Feller. Crk family adaptors–signalling complex formation and biological roles , 2001, Oncogene.
[33] R. Bast,et al. Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. , 2012, Endocrinology.
[34] A. Belmaaza,et al. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases , 2011, Molecular Genetics and Genomics.
[35] R. Lucito,et al. Protein-tyrosine Phosphatase 1B Antagonized Signaling by Insulin-like Growth Factor-1 Receptor and Kinase BRK/PTK6 in Ovarian Cancer Cells*♦ , 2013, The Journal of Biological Chemistry.
[36] M. Mann,et al. Decoding signalling networks by mass spectrometry-based proteomics , 2010, Nature Reviews Molecular Cell Biology.
[37] Yunbao Pan,et al. Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways , 2012, Oncogene.
[38] Min Liu,et al. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro. , 2008, Cancer letters.
[39] Yuan Tian,et al. Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics , 2011, Proteomics.
[40] Richard Simon,et al. Roadmap for developing and validating therapeutically relevant genomic classifiers. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] Andrew Emili,et al. Integrating gene and protein expression data: pattern analysis and profile mining. , 2005, Methods.
[42] C. Wolf,et al. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. , 1988, Carcinogenesis.